Clinical Study Results

• Tiotropium + BI 54903 - Asthma

  Clinical Study Number	1298.3
  Study Indication	Asthma
  Product	Tiotropium + BI 54903
  Generic Name	Tiotropium + BI 54903
  Lab Code
  Clinical Phase	II
  Study Title	A single dose, randomised, placebo-controlled, double-blind, 5-way crossover (employing an incomplete block design), efficacy (including 24-h pulmonary function tests) and safety comparison of Tiotropium/BI 54903 FDC ethanolic inhalation solution via Respimat® (doses of 1.23 μg/363.6 μg, 2.46 μg/363.6 μg or 4.93 μg/363.6 μg) versus free combination of Tiotropium aqueous inhalation solution via Respimat® (doses of 0, 2.5 μg, 5 μg or 10 μg) plus BI 54903 ethanolic inhalation solution via Respimat® (dose of 363.6 μg ) in patients with asthma
  Study Document	Trial statement 1298.3 english